6/26/2025

Shareholders of Thermo Fisher would probably like to forget the past six months even happened. The stock dropped 22% and now trades at $411.04. This might have investors contemplating their next move.

Source: Yahoo

6/26/2025

PT Diastika Biotekindo , alongstanding distributor in Indonesia’s medical equipment sector,is preparing to list its shares on the Indonesia Stock Exchange on July 10, Indonesia Business Post...

Source: Finnhub

6/25/2025

Thermo Fisher Scientific Inc. (NYSE:TMO) is one of the best S&P 500 stocks with huge upside potential. On June 23, Thermo Fisher Scientific announced that it had been awarded a 5-year contract worth $94.5 million by the US Department of Defense (DoD). Under this contract, Thermo Fisher Scientific will supply the US Navy with a […]

Source: Yahoo

6/25/2025

Solventum Removes Drinking-Water Unit From Thermo Fisher's Planned Filtration Buy

Source: MarketWatch

6/25/2025

Thermo Fisher Scientific Inc. stock rises Wednesday, outperforms market

Source: MarketWatch

6/25/2025

The oligonucleotide synthesis market is forecasted to grow from USD 10.5 billion in 2025 to USD 24.7 billion by 2030 (CAGR of 18.6%). Key drivers include increasing demand for synthesized oligonucleotides for research and diagnostics, along with advancements in synthesis technology. By 2024, the oligonucleotide-based drugs segment is expected to dominate, driven by rising acceptance for treating rare diseases. North America leads the market due to established healthcare infrastructure and strong

Source: Yahoo

6/25/2025

Backed by robust profitability, HOLX deploys billions into acquisitions and repurchases to boost future earnings.

Source: Yahoo

6/25/2025

Scope of Agreement with Cambrex to Provide Ondansetron HCL Drug Substance Under FDA Approved Drug Master File Scope Of Agreement With Thermo Fisher to Provide Manufacturing Services Including Demonstration, Clinical, Registration And Validation Batches of AD04 for US Clinical Trials And NDA Submission GLEN ALLEN, Va., June 25, 2025 (GLOBE NEWSWIRE) -- Adial Pharmaceuticals, Inc. (NASDAQ: ADIL) (“Adial” or the “Company”), a clinical-stage biopharmaceutical company focused on developing therapies

Source: Yahoo

6/25/2025

Thermo Fisher Scientific Inc. (NYSE:TMO) is one of the most active stocks to buy according to analysts. On June 13, Ethris announced a collaboration with Thermo Fisher Scientific. The partnership aims to provide a fully integrated messenger ribonucleic acid (mRNA) solution to biopharmaceutical developers globally. The core objective of the collaboration is to accelerate the […]

Source: Yahoo

6/24/2025

Xcell Biosciences announced a strategic collaboration with Thermo Fisher Scientific Inc. to advance research in regulatory T cells and tumor-infiltrating lymphocytes . While significant progress has...

Source: Finnhub

6/24/2025

Thermo Fisher Scientific Inc. stock rises Tuesday, still underperforms market

Source: MarketWatch

6/24/2025

We came across a bullish thesis on Thermo Fisher Scientific Inc. (TMO) on D Invests’ Substack. In this article, we will summarize the bulls’ thesis on TMO. Thermo Fisher Scientific Inc. (TMO)’s share was trading at $408.53 as of 9th June. TMO’s trailing and forward P/E were 23.96 and 18.21 respectively according to Yahoo Finance. Thermo Fisher […]

Source: Yahoo

6/24/2025

WALTHAM - Thermo Fisher Scientific, the world leader in serving science, today announced that it has been awarded a five-year, $94.5 million contract by the U.S. Department of Defense to supply the...

Source: Finnhub

6/21/2025

Discover why GE Healthcare is set for growth with strong innovation, backlog, and China's demand. Read more here.

Source: SeekingAlpha

6/20/2025

Thermo Fisher Scientific Inc. stock rises Friday, outperforms market

Source: MarketWatch

6/20/2025

It's easy to match the overall market return by buying an index fund. When you buy individual stocks, you can make...

Source: Yahoo

6/19/2025

Even though Waters Corporation has outshined the industry peers over the past year, Wall Street analysts maintain a cautiously optimistic outlook on the stock’s prospects.

Source: Yahoo

6/18/2025

This is our monthly dashboard series on Healthcare and Pharma stocks. Read the full analysis here, and which 10 healthcare stocks were cheaper than their peers in June 2025.

Source: SeekingAlpha

6/17/2025

Thermo Fisher’s first quarter results were met with a negative market reaction, as investors focused on the company’s exposure to new tariffs and shifting U.S. policy. Management attributed the flat sales to continued strength in core end markets like pharma and biotech, offset by declines in academic and government demand. CEO Marc Casper noted progress in bioproduction and pharma services, as well as robust electron microscopy sales, but acknowledged that macroeconomic uncertainty and reduced

Source: Yahoo

6/17/2025

Thermo Fisher Scientific Inc. stock falls Tuesday, underperforms market

Source: MarketWatch